Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II study of PSD502 for donor site pain in skin grafts
2005-004652-13Phase 2Terminated
- Sponsor
- Plethora Solutions
- Start
- Dec 2005
- Modality
- Small Molecules, Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Donor site pain after skin graft (DSP) comparing PSD502 with Placebo (2 arms). Primary endpoint: Primary efficacy variable. Started Dec 2005; status: terminated.
02
Drugs
lidocaine + prilocaine
03
Conditions
Donor site pain after skin graft (DSP)
Beyond the preview
Go deeper on 2005-004652-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-004652-13.